2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$1.34+$0.01 (+1.14%)
Price as of Jun 03, 2026 7:04 PM EDT- $37.5MMarket Cap
- -82.70%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$1.34+$0.01 (+1.14%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 50,000 +257.14% | 14,000 -90.97% | 155,000 -58.56% | 374,000 +106.63% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 50,000 +257.14% | 14,000 -90.97% | 155,000 -58.56% | 374,000 +106.63% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | 89,000 N/A | |
Research and Development Expense | -20.7M -37.71% | -33.2M +63.60% | -20.3M +18.78% | -17.1M -16.92% | |
Depreciation and Amortization Expense | 84,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 47.4M +11.22% | 42.6M +42.66% | 29.9M +13.57% | 26.3M -10.26% | |
Operating Profit | -47.4M +11.14% | -42.6M +43.35% | -29.7M +14.60% | -26.0M -10.98% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | 0 +100.00% | -789,000 -65.36% | -2.3M +13.11% | -2.0M N/A | |
Interest Income and Expense and Net | 0 +100.00% | -789,000 -65.36% | -2.3M +13.11% | -2.0M N/A | |
Total Nonoperating Income and Expense | 1.4M +162.21% | 553,000 +307.12% | -267,000 +8,800.00% | -3,000 -99.75% | |
Income before Taxes | -47.4M +11.14% | -42.6M +43.35% | -29.7M +14.60% | -26.0M -10.98% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 16.5M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -46.1M +9.54% | -42.1M +40.24% | -30.0M +9.92% | -27.3M -10.02% | |
Net Income from Continuing Operations Applicable to Common | 45.9M +209.15% | -42.1M +40.24% | -30.0M +9.92% | -27.3M -10.02% | |
Basic EPS and Net Income | -1.86 -11.85% | -2.11 +26.35% | -1.67 +9.87% | -1.52 -19.15% | |
Diluted EPS and Net Income | -1.86 -11.85% | -2.11 +26.35% | -1.67 +9.87% | -1.52 -19.15% | |
Basic Weighted Average Shares | 24.8M +24.13% | 19.9M +10.92% | 18.0M +0.30% | 17.9M +11.14% | |
Diluted Weighted Average Shares | 24.8M +24.13% | 19.9M +10.92% | 18.0M +0.30% | 17.9M +11.14% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 24.8M +18.30% | 20.9M -41.64% | 35.8M -31.26% | 52.2M -30.29% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 24.8M +18.30% | 20.9M -41.64% | 35.8M -31.26% | 52.2M -30.29% | |
Total Current Assets | 29.9M +31.88% | 22.7M -43.26% | 39.9M -38.24% | 64.7M -21.71% | |
Accumulated Depreciation | 87,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 955,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 595,000 +653.16% | 79,000 -39.69% | 131,000 +32.32% | 99,000 0.00% | |
Total Assets | 32.4M -18.23% | 39.6M -30.59% | 57.0M -30.31% | 81.8M -18.16% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 9.9M +98.42% | 5.0M +610.23% | |
Total Current Liabilities | 8.4M +16.55% | 7.2M -60.89% | 18.5M +69.12% | 10.9M +150.47% | |
Total Long-Term Debt | 15.0M 0.00% | 15.0M +54.69% | 9.7M 0.00% | 9.7M -32.93% | |
Total Long-Term Liabilities | 411,000 +68.44% | 244,000 -97.58% | 10.1M +1,819.01% | 526,000 -25.28% | |
Total Liabilities | 8.8M +18.25% | 7.5M -60.42% | 18.9M -13.04% | 21.7M +9.99% | |
Retained Earnings | -209.0M +28.16% | -163.1M +34.77% | -121.0M +32.97% | -91.0M +42.85% | |
Total Stockholders Equity | 23.5M -26.71% | 32.1M -14.04% | 37.3M -37.87% | 60.1M -25.08% | |
Total Shares Outstanding | 26.6M +19.32% | 22.3M +24.12% | 18.0M +0.03% | 17.9M +0.58% | |
Cash Flow | |||||
Cash from Operating Activities | -22.6M -32.31% | -33.4M +178.47% | -12.0M -47.19% | -22.7M -20.41% | |
Capital Expenditures | 1.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -1.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 27.6M +51.62% | 18.2M +531.03% | -4.2M -679.56% | 729,000 -99.24% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -94,766.00% -68.88% | -304,535.71% +1,487.14% | -19,187.74% +176.53% | -6,938.77% -56.92% | |
Return on Assets | -128.20% +47.08% | -87.16% +101.57% | -43.24% +43.93% | -30.04% -30.39% | |
Return on Equity | -165.75% +36.74% | -121.21% +96.80% | -61.59% +58.30% | -38.91% -23.71% | |
Revenue Growth | 257.14% +382.67% | -90.97% +55.35% | -58.56% -154.92% | 106.63% -93.16% | |
Current Ratio | 3.55 +13.16% | 3.14 +45.08% | 2.16 -63.48% | 5.92 -68.74% | |
Cash Ratio | 2.94 +1.50% | 2.90 +49.24% | 1.94 -59.36% | 4.78 -72.17% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.53 +114.89% | 0.24 +29.37% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.34 +91.54% | 0.18 +18.46% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow